Cost-effectiveness of budesonide/formoterol maintenance and rescue therapy in Thailand

1. Vichyanond P, Kaewsomboon S, Ruangrak S, Visitsunthorn N, Cherdjirapong V, Pongsamart G, et al. Increasing prevalence of allergic diseases among Thai children: The ISAAC III results. J Allergy Clin Immunol. 2003; 111 (Suppl 2):S310.10.1016/S0091-6749(03)81124-7Search in Google Scholar

2. Trakultivakorn M, Sangsupawanich P, Vichyanond P. Time trends of the prevalence of asthma, rhinitis and eczema in Thai children-ISAAC (International Study of Asthma and Allergies in Childhood) phase three. J Asthma. 2007; 44:609-11.10.1080/0277090070154011917943570Open DOISearch in Google Scholar

3. Vichyanond P, Jirapongsananuruk O, Visitsuntorn N, Tuchinda M. Prevalence of asthma, rhinitis and eczema in children from the Bangkok area using the ISAAC (International Study for Asthma and Allergy in Children) questionnaires. J Med Assoc Thai. 1998; 81: 175-84.Search in Google Scholar

4. Teeratakulpisarn J, Pairojkul S, Heng S. Survey of the prevalence of asthma, allergic rhinitis and eczema in schoolchildren from Khon Kaen, Northeast Thailand. an ISAAC study. International Study of Asthma and Allergies in Childhood. Asian Pac J Allergy Immunol. 2000; 18:187-94.Search in Google Scholar

5. Dejsomritrutai W, Nana A, Chierakul N, Tscheiguna J, Sompradeekul S, Rattanaumpawan P, et al. Prevalence of bronchial hyperresponsiveness and asthma in the adult population in Thailand. Chest. 2006; 129:602-9.10.1378/chest.129.3.60216537857Search in Google Scholar

6. Boonsawat W, Charoenphan P. Prevalence of asthma symptoms in adult in 4 cities of Thailand. Presented at Joint Scientific Meeting of Thoracic Soc Thailand, Malaysia Thoracic Soc and the Singapore Thoracic Soc. Bangkok, 2002, Bangkok.Search in Google Scholar

7. Boonsawat W, Charoenphan P, Kiatboonsri S, Wongtim S, Viriyachaiyo V, Photirat C, et al. Survey of asthma control in Thailand. Respirology. 2004; 9:373-8.10.1111/j.1440-1843.2004.00584.x15363011Open DOISearch in Google Scholar

8. Briggs AH, Bousquet J, Wallace MV, Busse WW, Clark TJH, Pedersen SE, et al. Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy. 2006; 61:531-6.10.1111/j.1398-9995.2006.01038.x16629780Search in Google Scholar

9. de Asis ML, Greene R. A cost-effectiveness analysis of a peak flow-based asthma education and selfmanagement plan in a high-cost population. J Asthma. 2004; 41:559-65.10.1081/JAS-120037657Search in Google Scholar

10. Ericsson K, Bantje TA, Huber RM, Borg S, Bateman ED. Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderatepersistent asthma. Respir Med. 2006; 100:586-94.10.1016/j.rmed.2005.09.03216274980Search in Google Scholar

11. Franco R, Santos AC, do Nascimento HF, Souza- Machado C, Ponte E, Souza-Machado A, et al. Costeffectiveness analysis of a state funded program for control of severe asthma. BMC Public Health. 2007; 7:82.10.1186/1471-2458-7-82189615917509137Search in Google Scholar

12. Lord J, Ducharme FM, Stamp RJ, Littlejohns P, Churchill R. Cost effectiveness analysis of inhaled anticholinergics for acute childhood and adolescent asthma. BMJ. 1999; 319:1470-1.10.1136/bmj.319.7223.14702829210582930Search in Google Scholar

13. Oba Y, Salzman GA. Cost-effectiveness analysis of omalizumab in adults and adolescents with moderateto- severe allergic asthma. J Allergy Clin Immunol. 2004; 114:265-9.10.1016/j.jaci.2004.05.04915316501Search in Google Scholar

14. Persson U, Ghatnekar O. Cost-effectiveness analysis of inhaled corticosteroids in asthma: a review of the analytical standards. Respir Med. 2003; 97:1-11.10.1053/rmed.2002.140512556004Search in Google Scholar

15. Pinnock H, McKenzie L, Price D, Sheikh A. Costeffectiveness of telephone or surgery asthma reviews: economic analysis of a randomised controlled trial. Br J Gen Pract. 2005; 55:119-24.Search in Google Scholar

16. Shih YC, Mauskopf J, Borker R. A cost-effectiveness analysis of first-line controller therapies for persistent asthma. Pharmacoeconomics. 2007; 25:577-90.10.2165/00019053-200725070-0000417610338Open DOISearch in Google Scholar

17. Sullivan SD, Buxton M, Andersson LF, Lamm CJ, Liljas B, Chen YZ, et al. Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol. 2003; 112:1229-36.10.1016/j.jaci.2003.09.02514657888Search in Google Scholar

18. Chuesakoolvanich K. Cost of hospitalizing asthma patients in a regional hospital in Thailand. Respirology 2007; 12:433-8.10.1111/j.1440-1843.2007.01032.x17539851Search in Google Scholar

19. Visitsunthorn N, Durongpisitkul W, Uoonpan S, Jirapongsananuruk O, Vichyanond P. Medical charge of asthma care in admitted Thai children. J Med Assoc Thai. 2005; 88 (Suppl 8):S16-20.Search in Google Scholar

20. O’Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005; 171:129-36.10.1164/rccm.200407-884OC15502112Search in Google Scholar

21. Kuna P, Peters MJ, Manjra AI, Jorup C, Naya IP, Martinez-Jimenez NE, et al. Effect of budesonide/ formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract. 2007; 61:725-36.10.1111/j.1742-1241.2007.01338.x192054717362472Open DOISearch in Google Scholar

22. Edejer TT-T, Baltussen R, Adam T, Hutubessy R, Acharya A, Evans DB, et al. editors. Making choices in health: WHO guide to cost-effectiveness analysis. Geneva: WHO 2003.Search in Google Scholar

23. Cook JR, Drummond M, Glick H, Heyse JF. Assessing the appropriateness of combining economic data from multinational clinical trials. Stat Med. 2003; 22: 1955-76.10.1002/sim.138912802815Search in Google Scholar

24. Karlsson G, Johannesson M. The decision rules of costeffectiveness analysis. Pharmacoeconomics. 1996; 9: 113-20.10.2165/00019053-199609020-0000310160090Open DOISearch in Google Scholar

25. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York:Chapman & Hall; 1993.10.1007/978-1-4899-4541-9Search in Google Scholar

26. Estimated population for Thai Kingdom.20528107Search in Google Scholar

27. Boonsawat W, Charoenphan P, Kiatboonsri S. Prevalence of asthma and rhinitis symptoms in adult in 4 cities of Thailand. Presented at 4th World Asthma Meeting, Bangkok, 2004.Search in Google Scholar

28. Brouwer W, Rutten F, Koopmanschap M. Costing in economic evaluations. In: Economic evaluation in health care - merging theory with practice. Drummond M, McGuire A, editors. New York: Oxford University Press; 2001.Search in Google Scholar

29. Cooper N, Coyle D, Abrams K, Mugford M, Sutton A. Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997. J Health Serv Res Policy. 2005; 10:245-50.10.1258/13558190577441418716259692Search in Google Scholar

30. Price D, Wiren A, Kuna P. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy. Allergy. 2007; 62:1189-98.10.1111/j.1398-9995.2007.01466.x17845590Search in Google Scholar

31. Chapman KR. Seretide for obstructive lung disease. Expert Opin Pharmacother. 2002; 3:341-50.10.1517/14656566.3.3.34111866683Search in Google Scholar

32. Main C, Shepherd J, Anderson R, Rogers G, Thompson- Coon J, Liu Z, et al. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with longacting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. Health Technol Assess. 2008; 12:1-174.10.3310/hta1220018485272Search in Google Scholar

33. Shepherd J, Rogers G, Anderson R, Main C, Thompson- Coon J, Hartwell D, et al. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over. Health Technol Assess. 2008; 12:1-254.10.3310/hta1219018485271Search in Google Scholar